Research identifies sex differences in SSc-ILD outcomes

Men with systemic sclerosis (SSc)-associated interstitial lung disease (ILD) may have a more severe disease course than women, whereas women with the condition could be more likely to experience certain adverse events (AEs) when treated with immunosuppressive therapy, suggest findings from two studies.
Read >

Pages